Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Brexit Deal Euphoria Sends FTSE To 9-Month High

Tue, 29th Dec 2020 12:24

(Alliance News) - Stocks in London were powering higher at midday on Tuesday following the Christmas break, with the FTSE 100 at a level last seen before the nationwide lockdown in March, as investors cheered a long-awaited, last-minute post-Brexit trade deal.

The FTSE 100 index was up 140.94 points, or 2.2%, at 6,643.05. The large cap index hit an intraday high of 6,676.60 in early trade - its highest reading since March.

The mid-cap FTSE 250 index was up 474.66 points, or 2.3%, at 21,021.31. The AIM All-Share index was up 1.8% at 1,147.86.

The Cboe UK 100 index was up 2.2% at 661.11. The Cboe 250 was up 2.3% at 18,353.40, and the Cboe Small Companies up 0.8% at 11,673.85.

In mainland Europe, the CAC 40 in Paris was up 0.3%, while the DAX 30 in Frankfurt was up 0.4%.

Last Thursday the UK reached an agreement with the European Union which allows for continued tariff-free trade with the EU single market.

"The FTSE 100 and FTSE 250 are both up nicely in the early exchanges and sterling is holding on to the USD1.35 and EUR1.10 marks, so markets seem to be welcoming the Brexit deal that was announced on Christmas Eve," said AJ Bell Investment Director Russ Mould. "However, the agreement struck between London and Brussels is yet to win universal acclaim, even if that is the inevitable result of the compromises that the prime minister had to make to get the deal over the line before the end of the transition period and confirmation of the UK's departure from the economic bloc."

EU ambassadors have given provisional approval for Britain's post-Brexit trade deal, which will be implemented from Friday.

A spokesman for the German EU presidency said the ambassadors had unanimously agreed to "green light" the settlement hammered out on Christmas Eve. It comes as UK MPs were preparing to vote on the deal in a special sitting of Parliament called for Wednesday.

The agreement came as ministers stepped up calls for businesses and individuals to prepare for the new procedures that will apply in just four days' time, regardless of the agreement.

In the FTSE 100, AstraZeneca was up 4.0%, amid hopes the Anglo-Swedish drugmaker's coronavirus vaccine, created in partnership with Oxford University, will be rolled out imminently.

Over the weekend, the Sunday Telegraph reported the Oxford jab could be rolled out en masse from a few days into the New Year.

According to the newspaper, the UK government hopes that the approval could mean more than two million could receive their first dose within a fortnight, with doses of the Oxford vaccine available from next Monday.

Further, AstraZeneca on Monday said its Lynparza cancer treatment has secured approval in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers.

Admiral Group was up 3.5%. The insurer said it has reached an agreement with ZPG Comparison Services Holdings UK's RVU business over the sale of the insurer's Penguin Portals and Preminen comparison businesses, for a total value of GBP508 million.

Penguin Portals is made up of online comparison portals Confused.com, Rastreator.com and LeLynx.fr, technology operations Admiral Technologies and its 50% share of Preminen Price Comparison Holdings.

Cardiff-based Admiral expects net proceeds of around GBP450 million, with a majority of this to be returned to shareholders. Admiral expects the deal to close in the first half of 2021. ZPG, which stands for Zoopla Property Group, will control the acquired businesses through its comparison site division, RVU - which operates Confused.com rival Uswitch.

At the other end of the large-cap index, banks were the worst performers amid uncertainty over future implications of the UK's Brexit deal on the financial services sector.

Lloyds Banking was down 3.8%, NatWest down 3.0%, Barclays,down 2.8%, and HSBC down 1.0%.

"First banks were lower because of no trade deal, now banks are lower because of a limited trade deal. There are many positives, but there will be a lot of disruptions in the UK banking circle getting access to the single market, but the problem is no one knows where financial services fit into this deal. Financial services were not a bigger priority in the deal," explained Axi's Stephen Innes. "It leaves a cloud of uncertainty hanging over London financial markets, and investors will have to wait until January to learn what type of access UK banks have to the single market."

Elsewhere in London, THG Holdings was up 5.2%. The Hut Group owner agreed to acquire US-based online skincare and specialty beauty brands retailer Dermstore.com, for USD350 million in cash from major retailer Target Corp, subject to US regulatory approval.

THG said the Dermstore.com acquisition provides the opportunity to accelerate the growth of its own beauty brands via a new and large US customer base.

In addition, THG acquired two of its long-standing UK-based nutrition product suppliers, Claremont Ingredients and David Berryman, for a combined purchase price of GBP59.5 million in cash.

The pound was quoted at USD1.3511 on Tuesday at midday, down from USD1.3587 at the London equities close on Christmas Eve.

The euro was priced at USD1.2250, up from USD1.2197. Against the yen, the dollar was trading at JPY103.63, flat from JPY103.62.

Brent oil was quoted at USD51.55 a barrel Tuesday at midday, sharply higher than USD50.74 at the London equities close Thursday. Gold was priced at USD1,879.35 an ounce, up from USD1,874.60.

"Investors are optimistic about oil prices, and they believe that the pandemic relief aid package along with the coronavirus vaccine should continue to improve oil demand. There is also optimism about the tightening of oil supply, and traders believe that US crude oil stockpiles should continue to see more tightening position," said AvaTrade analyst Naeem Aslam.

Wall Street has more records in its sights, as investors cheered the passage of a much-needed US stimulus bill. This has tempered fears about surging coronavirus infections.

The Dow Jones Industrial Average was called up 0.5%, the S&P 500 up 0.4% and the Nasdaq Composite up 0.5%. All three major indices set record closes on Monday.

US President Donald Trump signed into law the USD900 billion coronavirus relief bill and the USD1.4 trillion federal government budget on Sunday after days of delays. The move offers respite for investors following months of bickering between Democrats and Republicans over the size of the package.

In the latest developments, the US House of Representatives voted to increase Covid-19 relief cheques in the country to USD2,000, meeting Trump's demand for bigger payments and sending the bill to the Republican-controlled Senate, where the outcome is uncertain.

Democrats led passage of the motion, by 275 to 134, their majority favouring additional assistance. They had earlier settled for smaller USD600 payments in a compromise with Republicans over the big year-end relief bill Trump reluctantly signed into law.

The vote divides Republicans who mostly resist more spending, although many House Republicans joined in support, wary of opposing the president's wishes. Senators are set to return to session on Tuesday to consider the measure, with stiff resistance expected.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.